Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01950637 · ClinicalTrials.gov registry record
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 4,000
- Enrollment target
NCT01950637: Completed study, sponsored by Novo Nordisk A/S.
NCT01950637 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 4,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01950637 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 4,000 participants
- Enrollment target
Study Summary
This study is conducted Asia, Europe and North America. The aim of this study is to describe insulin therapy adherence and the burden of non-adherence on patient functioning, well-being and diabetes management.
Interventions
- BEHAVIORAL survey
- BEHAVIORAL No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-01 |
What the finished NCT01950637 record still lists
NCT01950637 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which survey is the first listed.
NCT01950637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01950637 about?
NCT01950637 is a clinical study titled "GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus". This study is conducted Asia, Europe and North America. The aim of this study is to describe insulin therapy adherence and the burden of non-adherence on patient functioning, well-being and diabetes management.
What is the current status of trial NCT01950637?
This trial is currently completed. The enrollment target is 4,000 participants. The study started on 2012-01. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01950637?
The interventions under investigation include: survey (BEHAVIORAL), No treatment given (BEHAVIORAL).
Who is sponsoring clinical trial NCT01950637?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia